NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/02/2026
Voltar para busca
Dado oficial do USPTO
MIDIAGNOSTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MIDIAGNOSTICS
ST13
US500000079183055Classe
5, 9, 10, 42, 44
Pedido
79183055
Registro
5864595
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
68
Atualização mais recente
27/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42, 44
Data de depósito
16/12/2015
Data de registro
24/09/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/01/2026
Última transação
27/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Leuven, BE
Examinador
KUNKLEMAN, SARAH E
Localização atual
Historical data usage
Titulares e representantes
Titulares
miDiagnostics, naamloze vennootschap
Representantes
Lindy M. Herman Rutan & Tucker LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationsdiagnostic reagents for medical and veterinary usefor medical in-vitro analysis and diagnosis in humans and animalsintegrated in an electronic deviceconsisting of one or more chips
Classe 9
Softwareincluding mobile applicationsfor performing an in-vitro analysis and medical diagnosis in humans and animalsthe storing and recording of this data and for transmitting the information recorded; computer software platforms for enabling users to operateclusterviewtrack and to research data related to health; electronic chipssemiconductor chips
Classe 10
Analysis and diagnostic devices for medical useintegrated in an electronic deviceconsisting of one or more chipsapparatus for performing a medical in-vitro analysis and medical diagnosis in humans and animals
Classe 42
Scientific and technological services and research and design relating theretoresearch and design in the field of in-vitro diagnosticsmedical research and scientific research information in the field of pharmaceuticals and clinical trials; medical research and scientific study and researchall in the fields of scientific and biotechnological facilities and research for the health care with regard to the productionvalidationdevelopmentstoragetransportuse in an electronic deviceconsisting of one or more chipsintegrated pharmaceutical compositions and in-vitro analysis and diagnostic tools; designinginstallingmaintainingdeveloping and updating softwaremobile software applications and computer software platforms; consultancy and providing information regarding the aforesaid servicesincluding provided via electronic networks such as the internet
Classe 44
Medical services and services in the field of healthcarehealthcare and providing healthcare information
Publicações
Histórico de despachos e eventos da marca no USPTO.
68 publicações encontradas
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
29/01/2026
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
29/01/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/01/2026
ES71
TEAS SECTION 71 RECEIVED
24/09/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
24/07/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
24/09/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
23/07/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/09/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
31/01/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
23/01/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/01/2020
FIMP
FINAL DISPOSITION PROCESSED
15/01/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/12/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
24/09/2019
GPNX
NOTIFICATION PROCESSED BY IB
19/07/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2019
PUBO
PUBLISHED FOR OPPOSITION
09/07/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/06/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
31/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/05/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
30/05/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30/05/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
30/05/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/05/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
30/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/05/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
29/05/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/05/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
29/05/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/05/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/12/2018
GNFR
FINAL REFUSAL E-MAILED
08/12/2018
CNFR
FINAL REFUSAL WRITTEN
08/12/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/11/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
19/11/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
17/07/2018
ALIE
ASSIGNED TO LIE
17/07/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/01/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/08/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/07/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/07/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
19/06/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/12/2016
GNSL
LETTER OF SUSPENSION E-MAILED
13/12/2016
CNSL
SUSPENSION LETTER WRITTEN
13/12/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2016
ALIE
ASSIGNED TO LIE
09/12/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
23/11/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
26/10/2016
GNSL
LETTER OF SUSPENSION E-MAILED
26/10/2016
CNSL
SUSPENSION LETTER WRITTEN
26/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2016
RFNT
REFUSAL PROCESSED BY IB
13/05/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/04/2016
RFRR
REFUSAL PROCESSED BY MPU
06/04/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/04/2016
CNRT
NON-FINAL ACTION WRITTEN
05/04/2016
DOCK
ASSIGNED TO EXAMINER
04/04/2016
MAFR
APPLICATION FILING RECEIPT MAILED
23/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/02/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/02/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MIDIAGNOSTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.